Modulation of methylnitrosourea-induced breast cancer in sprague dawley rats by dehydroepiandrosterone: Dose-dependent inhibition, effects of limited exposure, effects on peroxisomal enzymes, and lack of effects on levels of Ha-Ras mutations

Cancer Research

Volumn 58, Issue 5, 1998, Pages 921-926

  Lubet, Ronald A ^a   Gordon, Gary B ^b,c   Prough, Russell A ^d   Lei, Xiang Dong ^d   You, Ming ^e   Wang, Yian ^e   Grubbs, Clinton J ^f   Steele, Vernon E ^a   Kelloff, Gary J ^a   Thomas, Cathy F ^g   Moon, Richard D ^g  

^a NATIONAL CANCER INSTITUTE   (United States)

^b PFIZER INC   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d University of Louisville School of Medicine   (United States)

^e MEDICAL COLLEGE OF OHIO   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LONG CHAIN FATTY ACID COENZYME A LIGASE; METHYLNITROSOUREA; PRASTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER PREVENTION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; FEMALE; GENE MUTATION; NONHUMAN; ONCOGENE H RAS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMALS; CELL DIVISION; COENZYME A LIGASES; DEHYDROEPIANDROSTERONE; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENES, RAS; MAMMARY NEOPLASMS, ANIMAL; METHYLNITROSOUREA; MICROBODIES; MUTATION; NEOPLASMS, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032031874     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Vande Wiele, R., and Lieberman, S. The metabolism of dehydroisoandrosterone. In: G. Pincus and E. Volmer (eds.), Biologic Activity of Steroids in Relation to Cancer, pp. 93-110. New York: Academic Press, Inc., 1960.
2. Adams, J. B. Control of secretion and function of C19 delta-5 steroids of the human adrenal gland. Mol. Cell. Endocrinol., 41: 1-17, 1984.
3. Carlstrom, K., Brody, S., Lunnell, N. O., Lagrelius, A., Mollerstrom, G., Pousette, A., Rannevik, G., Stege, R., and von Schoultz, B. Dehydroepiandrosterone-sulfate and dehydroepiandrosterone in serum: differences related to age and sex. Marutitas, 10: 297-306, 1988.
4. Bullbrook, R. D., Hayward, J. L., and Spicer, C. C. Relation between urinary androgen and corticoid excretion and subsequent breast cancer. Lancet, ii: 395-398, 1971.
5. Gordon, G. B., Bush, T. L., Helzlsouer, K. J., Miller, S. R., and Comstock, G. W. Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer. Cancer Res., 5: 3589-3862, 1990.
6. Dorgan, J. F., Stanczyk, F. Z., Longscope, C., Stephenson, H. E., Chang, L., Miller, R., Franz, C., Falk, R. T., and Kahle, L. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3β,17β-diol to risk of breast cancer in postmenopausal women. Cancer Epidemiol. Biomark. Prev., 6: 177-181, 1997.
7. Schwartz, A. G., Fairman, D. K., Polansky, M., Lewbart, M. L., and Pashko, L. L. Inhibition of 7,12-dimethylbenzanthracene initiated and TPA-promoted skin papilloma formation in mice by dehydroepiandrosterone and two synthetic analogs. Carcinogenesis (Lond.), 10: 1809-1813, 1989.
8. Nyce, J. W., Magee, P. N., Hard, G. C., and Schwartz, A. G. Inhibition of 1,2-dimethylhydrazine induced colon tumorigenesis in Balb/c mice by dehydroepiandrosterone. Carcinogenesis (Lond.), 5: 57-62, 1984.
9. Perkins, S. N., Hursting, S. D., Haines, D. C., James, S. J., Miller, B. J., and Phang, J. M. Chemoprevention of spontaneous tumorigenesis in nullizygous P53 deficient mice by dehydroepiandrosterone and its analog, 16α-fluoro-5-androsten-17-one. Carcinogenesis (Lond.), 18: 989-994, 1997.
10. Schwartz, A. G., and Tannen, R. H. Inhibition of 7,12-dimethylbenzanthracene and urethan induced lung tumor formation in A/J mice by long term treatment with dehydroepiandrosterone. Carcinogenesis (Lond.), 2: 1335-1337, 1981.
11. Li. S., Yan, X., Belanger, A., and Labrie, F. Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenzanthracene (DMBA) in the rat. Breast Cancer Res. Treat., 29: 203-217, 1993.
12. Ratko, T. A., Detrisiac, C. J., Mehta, R. G., Kelloff, G. J., and Moon, R. C. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone. Cancer Res., 51: 481-486, 1991.
13. McCormick, D. L., Rao, K. V., Johnson, W. D., Bowman-Gram, T. A., Steele, V. E., Lubet, R. A., and Kelloff, G. J. Exceptional chemopreventive activity of low dose dehydroepiandrosterone in the rat mammary gland. Cancer Res., 56: 1724-1727, 1996.
14. Inano, H., Ishii-Ohba, H., Suzuki, K., Yamanouchi, H., Onada, M., and Wakabayashi, K. Chemoprevention by dietary 7-dehydroepiandrosterone against promotion/progression phase of radiation-induced mammary tumorigenesis in rats. J. Steroid Biochem. Mol. Biol., 54: 47-53, 1995.
15. Schwartz, A., and Pashko, L. Mechanism of cancer preventive action of DHEA. Ann. NY Acad. Sci., 774: 180-186, 1995.
16. Guillino, P., Pettigrew, H., and Grantham, F. N. Nitrosomethylurea is a mammary gland carcinogen in rats. J. Natl. Cancer Inst., 54: 401-414, 1975.
17. McCormick, D. L., Adamowski, C. B., Fiks, A., and Moon, R. C. Lifetime dose response relationships for mammary tumor induction by a single administration of N-methyl-N-nitrosourea. Cancer Res., 41: 1690-1694, 1981.
18. Peto, J. The calculation and interpretation of survival curves. In: Cancer Clinical Trials: Methods and Practice, pp. 361-380. Oxford, England: Oxford University Press, 1980.
19. 2 test for heterogeneity of proportion after adjustment for stratification. J. Royal Statistical Soc. B, 28: 150-163, 1966.
20. Holtzclaw, W. D., and Gordon, G. B. Measurement of serum levels of dehydroepiandrosterone sulfate: a comparison of radioimmunoassay and enzymatic analysis. Steroids, 54: 355-371, 1989.
21. Wang, W., You, M., Reynolds, S. H., Stoner, G. D., and Anderson, M. W. Mutational activation of cellular Harvey ras gene in methylbenzylnitrosoamine induced Fisher F344 rat esophageal papillomas. Cancer Res., 50: 1591-1595, 1989.
22. Wu, H-Q., Masset-Brown, J., Tweedy, D. J., Milewich, L., Frenkel, R. A., Martin-Wixtrom, C., Estabrook, R. W., and Prough, R. A. Induction of microsomal NADPH cytochrome P-450 reductase and cytochrome P450 IVA1 (P450 law) by dehydroepiandrosterone in rats: a possible peroxisome proliferator. Cancer Res., 49: 2337-2343, 1989.
23. Luo, S., Labrie, C., Belanger, A., and Labrie, F. Effect of dehydroepiandrosterone on bone mass, serum lipids and DMBA induced mammary carcinoma in the rat. Endocrinology, 138: 3387-3394, 1997.
24. Berdanier, C. D., Parente, J. A., and McIntosh, M. K. Is dehydroepiandrosterone an antiobesity agent? FASEB J., 7: 414-419, 1993.
25. Sukumar, S., Notario, V., Martin-Zanca, D., and Barbacid, M. Induction of mammary carcinomas in rats by nitrosomethylurea involves malignant activation of H-ras-1 locus by single point mutations. Nature (Lond.), 306: 658-661, 1983.
26. Cha, R. S., Thilly, W. G., and Zarbl, H. MNU-induced rat mammary tumors arise from cells with preexisting oncogenic Hras-1 gene mutations. Proc. Natl. Acad. Sci. USA, 91: 3749-3753, 1994.
27. Leighton, B., Tagliaferro, A. R., and Newsholme, E. A. The effect of dehydroepiandrosterone acetate on liver peroxisomal enzyme activities on male and female rats. J. Nutr., 117: 1287-1290, 1987.
28. Reddy, J. K., Goel, S. K., Nemali, M. R., Carrino, J. J., Laffler, T. G., Reddy, M. K., Sperbeck, S. J., Osumi, T., Hashimoto, T., and Lawani, N. D. Transcriptional regulation of peroxisomal fatty acyl Co-A oxidase and enoyl-coA hydratase/3-hydroxyacyl-co-A dehydrogenase in rat liver by peroxisome proliferators. Proc. Natl. Acad. Sci. USA, 83: 1747-1751, 1986.
29. Schwartz, A. G., and Pashko, L. L. Mechanism of cancer preventive action of DHEA. Role of glucose-6-phosphate dehydrogenase. Ann. NY Acad. Sci., 774: 180-186, 1995.
30. Shantz, L. M., Talalay, P., and Gordon, G. B. Mechanism of inhibition of growth of 3T3-L1 fibroblasts and their differentiation to adipocytes by dehydroepiandrosterone and related steroids: role of glucose-6-phosphate dehydrogenase. Proc. Natl. Acad. Sci. USA, 86: 3952-3856, 1989.
31. Schulz, S., and Nyce, J. W. Inhibition of protein farnesyltranferase: a possible mechanism of tumor prevention by dehydroepiandrosterone sulfate. Carcinogenesis (Lond.), 15: 2649-2655, 1994.
32. Russo, I. H., and Russo, J. Physiologic basis of breast cancer prevention. Eur. J. Cancer Prev., 2: 101-111, 1993.